Parties
Company
Bright Minds Biosciences Inc.
Company
Cormorant Asset Management
Bright Minds Biosciences Inc. closed a US$35 million non-brokered private placement, comprised of common shares priced at US$21.70 each and pre-funded warrants at US$21.699 per warrant.
Prominent healthcare investors participated, including Cormorant Asset Management, RA Capital Management, Perceptive Advisors, Janus Henderson Investors, Vivo Capital, Acuta Capital Partners, and Schonfeld Strategic Advisors.
Deal Type
Public/Private OfferingIndustry
HealthcareTransaction
$ 49,221,025Deal Status
ClosedClosing Date
04 November 2024